This document is a publication of a European patent application (EP4630064A1) by the European Patent Office (EPO). The patent, titled 'ALPHA EMITTER LABELLED SOMATOSTATIN RECEPTOR ANTAGONISTS,' was published on March 18, 2026. Ariceum Therapeutics GmbH is listed as the applicant, and specific inventors are named. The application includes IPC classifications related to pharmaceutical compounds and their use.

As this is a patent publication, it does not impose new regulatory obligations or compliance deadlines on regulated entities. It represents a disclosure of intellectual property related to potential therapeutic agents. Compliance officers in the pharmaceutical sector should note this publication as part of ongoing landscape monitoring for new drug development and patent filings.